GlassScriptPhysician profile
James T Beckmann
NPI 1164657854
$7,543.06
in general payments reported to CMS, 2019-2025
11 companies · $377 in 2025
The $377 reported for 2025 was less than what a typical Orthopaedic Surgery provider received nationally (typical 2025 total: $569).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $61.70 · 2020: $742 · 2021: $3,489 · 2022: $2,418 · 2023: $53.34 · 2024: $402 · 2025: $377.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $833.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $832.72 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Stryker Corporation | $3,909.94 | 2020-2025 | Iconix, Augment Injectable, Na |
| Steelhead Surgical INC | $2,955.81 | 2020-2022 | |
| Vericel Corporation | $196.43 | 2019-2025 | Maci |
| Miach Orthopaedics, INC. | $181.01 | 2025 | |
| Vertex Pharmaceuticals Incorporated | $122.02 | 2025 | |
| Ossur Americas, INC. | $75.68 | 2024 | Miami J |
| Ferring Pharmaceuticals INC. | $43.90 | 2019 | |
| Depuy Synthes Sales INC. | $27.23 | 2020-2023 | Gryphon Orthocord, Healix Knotless Peek |
| Bioventus LLC | $16.96 | 2020 | |
| Sawtooth Surgical Solutions INC | $14.08 | 2025 |
1 company reported research payments only; those appear in the research section below.
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw James Beckmann listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.